We are live on ! Find out more
FATE icon

Fate Therapeutics

16 hedge funds and large institutions have $24.7M invested in Fate Therapeutics in 2013 Q4 according to their latest regulatory filings, with 16 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
16
Holders Change
+16
Holders Change %
% of All Funds
0.46%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
16
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Wellington Management Group
1
Wellington Management Group
Massachusetts
$7.52M +$7.54M +1,197,200 New
KCM
2
Kingdon Capital Management
New York
$5.41M +$5.43M +861,802 New
O
3
OrbiMed
New York
$4.41M +$4.42M +702,000 New
FCM
4
Farallon Capital Management
California
$3.42M +$3.43M +544,243 New
BOTOTLSJU
5
Board of Trustees of The Leland Stanford Junior University
California
$1.91M +$1.91M +303,538 New
Principal Financial Group
6
Principal Financial Group
Iowa
$1.27M +$1.27M +201,900 New
Goldman Sachs
7
Goldman Sachs
New York
$257K +$258K +40,991 New
Millennium Management
8
Millennium Management
New York
$165K +$165K +26,201 New
Vanguard Group
9
Vanguard Group
Pennsylvania
$116K +$117K +18,526 New
Deutsche Bank
10
Deutsche Bank
Germany
$115K +$116K +18,500 New
TRCT
11
Tower Research Capital (TRC)
New York
$66K +$65.7K +10,441 New
U
12
UBS
Switzerland
$11K +$10.8K +1,717 New
PNC Financial Services Group
13
PNC Financial Services Group
Pennsylvania
$6K +$6.3K +1,000 New
Bank of America
14
Bank of America
North Carolina
$6K +$6.52K +1,035 New
AIG
15
American International Group
New York
$622 +$623 +99 New
Citigroup
16
Citigroup
New York
+$296 +47 New